Connolly Timothy A
Houston Methodist Hospital, Houston, Texas.
Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4 Suppl):17. doi: 10.14797/mdcj-12-4s1-17.
Chronic obstructive pulmonary disease remains a major cause of morbidity and mortality worldwide. Despite regular advances in pharmacology, there remains great potential for addressing structural deficiencies, especially in emphysema. The loss of alveolar attachments to small bronchial tubes results in diffuse loss of elastic recoil and airway collapse during exhalation. This appears physiologically as hyperinflation of lung volumes with flattened diaphragms and significantly elevated residual volumes (RV) on pulmonary function testing (predicted RV > 175%).
慢性阻塞性肺疾病仍然是全球发病和死亡的主要原因。尽管药理学不断取得进展,但解决结构缺陷仍有很大潜力,尤其是在肺气肿方面。肺泡与小支气管之间连接的丧失导致呼气时弹性回缩力弥漫性丧失和气道塌陷。这在生理上表现为肺容积过度膨胀,膈肌变平,肺功能测试中残气量(RV)显著升高(预测RV>175%)。